Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa (VPA_RP)
This study is ongoing, but not recruiting participants.
Study NCT01399515   Information provided by Seoul National University Hospital

First Received on May 3, 2011.   Last Updated on April 17, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Retinitis Pigmentosa
Retinal Diseases
Eye Diseases
Eye Disease, Hereditary
Retinal Degeneration
Additional conditions recognized in this trial
Eye Diseases, Hereditary
Genetic Diseases, Inborn
Retinitis
More general conditions related to this trial
Retinal Dystrophies
Interventions listed in this trial
Valproic Acid
More general drug interventions related to this trial
Anticonvulsants
Antimanic Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
GABA Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Seoul National University Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services